Search research articles
Contact Us
Filters
Showing results (81-90 of 589) with videos related to
Page
of 59
Sort By:
Immunologic Research
|
June 8, 2004
Ocular immune privilege and CTL tolerance
Kyle C McKenna, Judith A Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
November 15, 2006
[Specific immunotherapy in the treatment of atopic dermatitis]
M Niebuhr, A Kapp, T Werfel
The Journal of Experimental Medicine
|
September 1, 1986
Bystander help in primary immune responses in vivo
P E Jensen, J A Kapp
Allergy
|
April 1, 1997
Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions
T Werfel, M Boeker, A Kapp
Archives of Dermatological Research
|
January 1, 1986
Inhibitory effect of sulfonated shale oils (ammonium bituminosulfonate) on the stimulation of neutrophilic granulocytes by the chemotactic tripeptide f-Met-Leu-Phe
E Kownatzki, A Kapp, S Uhrich
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Immunosuppressive factor(s) from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). V. Inhibition of T cell proliferative responses
B A Araneo, J A Kapp
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2006
Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye
Kyle C McKenna, Judith A Kapp
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1978
H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin
J A Kapp, D S Strayer
Immunologic Research
|
June 8, 2004
Identification and characterization of CD8+ suppressor T cells
James C Zimring, Judith A Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 20, 2014
[Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab]
D Wieczorek, A Kapp, B Wedi
Page
of 59
Search research articles
Search
Showing results (81-90 of 589) with videos related to
Sort By:
Page
of 59
Immunologic Research
|
June 8, 2004
Ocular immune privilege and CTL tolerance
Kyle C McKenna, Judith A Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
November 15, 2006
[Specific immunotherapy in the treatment of atopic dermatitis]
M Niebuhr, A Kapp, T Werfel
The Journal of Experimental Medicine
|
September 1, 1986
Bystander help in primary immune responses in vivo
P E Jensen, J A Kapp
Allergy
|
April 1, 1997
Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions
T Werfel, M Boeker, A Kapp
Archives of Dermatological Research
|
January 1, 1986
Inhibitory effect of sulfonated shale oils (ammonium bituminosulfonate) on the stimulation of neutrophilic granulocytes by the chemotactic tripeptide f-Met-Leu-Phe
E Kownatzki, A Kapp, S Uhrich
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Immunosuppressive factor(s) from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). V. Inhibition of T cell proliferative responses
B A Araneo, J A Kapp
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2006
Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye
Kyle C McKenna, Judith A Kapp
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1978
H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin
J A Kapp, D S Strayer
Immunologic Research
|
June 8, 2004
Identification and characterization of CD8+ suppressor T cells
James C Zimring, Judith A Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 20, 2014
[Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab]
D Wieczorek, A Kapp, B Wedi
Page
of 59